lobbying_activities: 1449013

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1449013	1abd701c-86f3-462e-a30f-1e7bdfd2b188	Q3	EMPIRE CONSULTING GROUP	400703105	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2013	third_quarter	PHA	Issues relating to the Medicare Prescription Drug Act; issues relating to implementation of the Affordable Care Act; H.R. 1588, "Medicare Drug Savings Act of 2013"; 340 B Drug Discount Program; HR 3204, Drug Quality & Security Act	HOUSE OF REPRESENTATIVES	40000		0	0	2013-10-17T18:25:45.463000-04:00